During the past decade, Wansford And Kings Cliffe Practice conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wansford And Kings Cliffe Practice" are "Cardiovascular Disease" (2 trials), "Subjective Tinnitus" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials) and "Dyslipidemic" (1 trials). Many other conditions were trialed in "Wansford And Kings Cliffe Practice" in a lesser frequency.

Most popular intervention types in "Wansford And Kings Cliffe Practice" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Neramexane mesylate" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wansford And Kings Cliffe Practice" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Wansford And Kings Cliffe Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wansford And Kings Cliffe Practice, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wansford And Kings Cliffe Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".